These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26900655)

  • 21. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
    El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
    Bajaj S; Kumar MS; Tinwala H; Yc M
    Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents.
    Du QR; Li DD; Pi YZ; Li JR; Sun J; Fang F; Zhong WQ; Gong HB; Zhu HL
    Bioorg Med Chem; 2013 Apr; 21(8):2286-2297. PubMed ID: 23490159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
    Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
    Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Biological Evaluation of the Matrine Derivatives as a Novel Family of Potential Anticancer Agents.
    Wang J; Liu H; Zhuo XB; Ye GM; Zhao QJ
    Med Chem; 2021; 17(5):493-500. PubMed ID: 31642790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units.
    He X; Li XY; Liang JW; Cao C; Li S; Zhang TJ; Meng FH
    Bioorg Med Chem Lett; 2018 Mar; 28(5):847-852. PubMed ID: 29456106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity, Pro-apoptotic Activity and in silico Studies of Dithiocarbamates and their Structure Based Design and SAR Studies.
    Hamdani SS; Khan BA; Hameed S; Rashid F; Zaib S; Ahmad K; Mughal EU; Iqbal J
    Med Chem; 2019; 15(8):892-902. PubMed ID: 30747078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and optimization of 2-thio-5-amino substituted benzoquinones as potent anticancer agents.
    Zhao Y; Lu Y; Li R; He J; Zhang H; Wang X; Ge Z; Li R
    Eur J Med Chem; 2018 Apr; 149():1-9. PubMed ID: 29486369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Screening of 5-Aryl-3-(2-(pyrrolyl)thiophenyl)-1,2,4-oxadiazoles as Potential Antitumor Molecules on Breast Cancer MCF-7 Cell Line.
    Abd El Hameid MK
    Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1181-1195. PubMed ID: 30298827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
    Khalil NA; Kamal AM; Emam SH
    Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
    Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
    Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
    Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
    Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity.
    Porta F; Gelain A; Barlocco D; Ferri N; Marchianò S; Cappello V; Basile L; Guccione S; Meneghetti F; Villa S
    Chem Biol Drug Des; 2017 Nov; 90(5):820-839. PubMed ID: 28419754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamate-nitrostyrene hybrid as potent antiproliferative and apoptotic inducing agent against cervical cancer cell lines.
    Laskar S; Sánchez-Sánchez L; Flores SM; López-Muñoz H; Escobar-Sánchez ML; López-Ortiz M; Hernández-Rodríguez M; Regla I
    Eur J Med Chem; 2018 Feb; 146():621-635. PubMed ID: 29407986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors.
    Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A
    Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone.
    Luo ZH; He SY; Chen BQ; Shi YP; Liu YM; Li CW; Wang QS
    Chem Pharm Bull (Tokyo); 2012; 60(7):887-91. PubMed ID: 22790823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
    El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.